Magnetic resonance imaging of rectal and anal cancer

Magnetic Resonance Imaging Clinics of North America

Volumn 22, Issue 1, 2014, Pages 85-112

  Torkzad, Michael R ^a   Kamel, Ihab ^b   Halappa, Vivek Gowdra ^b   Beets Tan, Regina G H ^c  

^a UPPSALA UNIVERSITY   (Sweden)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anus; Cancer; Magnetic resonance imaging; Rectum; Staging

Indexed keywords

MUCIN;

ANUS CARCINOMA; CANCER GROWTH; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CLINICAL EVALUATION; HUMAN; INTESTINE MUSCLE; MUSCULARIS PROPRIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE CARE; PRIMARY TUMOR; PROTEIN SYNTHESIS; RECTUM CARCINOMA; RECURRENT CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR INVASION;

ANUS; CANCER; MAGNETIC RESONANCE IMAGING; RECTUM; STAGING;

ANAL CANAL; ANUS NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; RECTAL NEOPLASMS; RECTUM;

EID: 84887618585     PISSN: 10649689     EISSN: 15579786     Source Type: Journal    
DOI: 10.1016/j.mric.2013.07.007     Document Type: Review

References (37)

1. Glynne-Jones R., Northover J.M., Cervantes A. Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010, 21(Suppl 5):v87-v92.
2. Birgisson H., Talbäck M., Gunnarsson U., et al. Improved survival in cancer of the colon and rectum in Sweden. Eur J Surg Oncol 2005, 31(8):845-853.
3. den Dulk M., Krijnen P., Marijnen C.A., et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer 2008, 44(12):1710-1716.
4. Lemmens V., van Steenbergen L., Janssen-Heijnen M., et al. Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival. Acta Oncol 2010, 49(6):784-796.
5. Oistämö E., Hjern F., Blomqvist L., et al. Cancer and diverticulitis of the sigmoid colon. Differentiation with computed tomography versus magnetic resonance imaging: preliminary experiences. Acta Radiol 2013, 54(3):237-241.
6. Heald R.J., Ryall R.D. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986, 1:1479-1482.
7. Beets-Tan R.G., Beets G.L., Vliegen R.F., et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001, 357(9255):497-504.
8. Beets-Tan R.G., Lambregts D.M., Maas M., et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 2013, 10.1007/s00330-013-2864-4.
9. Shihab O.C., Quirke P., Heald R.J., et al. Magnetic resonance imaging-detected lymph nodes close to the mesorectal fascia are rarely a cause of margin involvement after total mesorectal excision. Br J Surg 2010, 97(9):1431-1436.
10. Torkzad M.R., Påhlman L., Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging 2010, 1(4):245-267.
11. Shihab O.C., Heald R.J., Rullier E., et al. Defining the surgical planes on MRI improves surgery for cancer of the low rectum. Lancet Oncol 2009, 10(12):1207-1211.
12. Gowdra Halappa V., Corona Villalobos C.P., Bonekamp S., et al. Rectal imaging: part 1, High-resolution MRI of carcinoma of the rectum at 3 T. AJR Am J Roentgenol 2012, 199(1):W35-W42.
13. Fütterer J.J., Yakar D., Strijk S.P., et al. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and three-dimensional T2-weighted turbo spin echo sequence. Eur J Radiol 2008, 65(1):66-71.
14. Kim S.H., Lee J.M., Hong S.H., et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology 2009, 253(1):116-125.
15. Dinter D.J., Hofheinz R.D., Hartel M., et al. Preoperative staging of rectal tumors: comparison of endorectal ultrasound, hydro-CT, and high-resolution endorectal MRI. Onkologie 2008, 31(5):230-235.
16. Slater A., Halligan S., Taylor S.A., et al. Distance between the rectal wall and mesorectal fascia measured by MRI: effect of rectal distension and implications for preoperative prediction of a tumour-free circumferential resection margin. Clin Radiol 2006, 61(1):65-70.
17. MERCURY Study Group Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007, 243(1):132-139.
18. Smith N.J., Shihab O., Arnaout A., et al. MRI for detection of extramural vascular invasion in rectal cancer. AJR Am J Roentgenol 2008, 191(5):1517-1522.
19. Yantiss R.K., Shia J., Klimstra D.S., et al. Prognostic significance of localized extra-appendiceal mucin deposition in appendiceal mucinous neoplasms. Am J Surg Pathol 2009, 33(2):248-255.
20. Syk E., Torkzad M.R., Blomqvist L., et al. Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 2006, 93(1):113-119.
21. Matsuoka H., Nakamura A., Masaki T., et al. Optimal diagnostic criteria for lateral pelvic lymph node metastasis in rectal carcinoma. Anticancer Res 2007, 27(5B):3529-3533.
22. Guillem J.G., Díaz-González J.A., Minsky B.D., et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. JClin Oncol 2008, 26(3):368-373.
23. Vliegen R.F., Beets G.L., Lammering G., et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008, 246(2):454-462.
24. Torkzad M.R., Suzuki C., Tanaka S., et al. Morphological assessment of the interface between tumor and neighboring tissues, by magnetic resonance imaging, before and after radiotherapy in patients with locally advanced rectal cancer. Acta Radiol 2008, 49(10):1099-1103.
25. Lahaye M.J., Beets G.L., Engelen S.M., et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?. Radiology 2009, 252(1):81-91.
26. Dresen R.C., Beets G.L., Rutten H.J., et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall?. Radiology 2009, 252(1):71-80.
27. Torkzad M., Lindholm J., Martling A., et al. Retrospective measurement of different size parameters of non-radiated rectal cancer on MR images and pathology slides and their comparison. Eur Radiol 2003, 13(10):2271-2277.
28. Torkzad M.R., Lindholm J., Martling A., et al. MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry. Eur Radiol 2007, 17(6):1566-1573.
29. Rosenberg R., Herrmann K., Gertler R., et al. The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT. Int J Colorectal Dis 2009, 24(2):191-200.
30. Smith J.A., Wild A.T., Singhi A., et al. Clinicopathologic comparison of high-dose-rate endorectal brachytherapy versus conventional chemoradiotherapy in the neoadjuvant setting for resectable stages II and III low rectal cancer. Int J Surg Oncol 2012, 2012:406568.
31. Messiou C., Chalmers A.G., Boyle K., et al. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 2008, 81(966):468-473.
32. Syk E., Torkzad M.R., Blomqvist L., et al. Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys 2008, 72(3):658-664.
33. Kochhar R., Plumb A.A., Carrington B.M., et al. Imaging of anal carcinoma. AJR Am J Roentgenol 2012, 199:W335-W344.
34. Roach S.C., Hulse P.A., Moulding F.J., et al. Magnetic resonance imaging of anal cancer. Clin Radiol 2005, 60:1111-1119.
35. Tonolini M., Bianco R. MRI and CT of anal carcinoma: a pictorial review. Insights Imaging 2013, 4(1):53-62.
36. Wells I.T., Fox B.M. PET/CT in anal cancer - is it worth doing?. Clin Radiol 2012, 67(6):535-540.
37. Bhuva N.J., Glynne-Jones R., Sonoda L., et al. To PET or not to PET? That is the question. Staging in anal cancer. Ann Oncol 2012, 23(8):2078-2082.